share_log

康希諾生物：2023年股東週年大會的投票表決結果；及選舉第三屆董事會非執行董事

CANSINOBIO: POLL RESULTS OF THE 2023 ANNUAL GENERAL MEETING; AND ELECTION OF NON-EXECUTIVE DIRECTOR OF THIRD SESSION OF BOARD OF DIRECTORS

HKEX ·  Jun 27 22:03

Summary by Moomoo AI

康希諾生物於2024年6月27日舉行的2023年股東週年大會上，所有提案均獲正式通過。會議中，李志成先生被選舉為第三屆董事會非執行董事。該次大會的出席股東所持股份數目約占已發行股份的34.29%，其中H股和A股的出席比例分別為29.12%和40.28%。會議通過的重要決議包括董事會報告、監事會報告、年度報告及其摘要、財務決算報告及財務審計報告、利潤分配方案、重新委任德勤為2024年度國際核數師等。此外，還通過了關於未彌補虧損、股東分紅回報規劃、董事會一般授權、發行債務融資工具等議案。監票工作由香港中央證券登記有限公司負責，並有股東代表、律師及監事參與。董事會成員包括執行董事Xuefeng YU博士、Shou Bai CHAO博士、王靖女士，非執行董事李志成先生，以及獨立非執行董事桂水發先生、劉建忠先生及張耀樑先生。
康希諾生物於2024年6月27日舉行的2023年股東週年大會上，所有提案均獲正式通過。會議中，李志成先生被選舉為第三屆董事會非執行董事。該次大會的出席股東所持股份數目約占已發行股份的34.29%，其中H股和A股的出席比例分別為29.12%和40.28%。會議通過的重要決議包括董事會報告、監事會報告、年度報告及其摘要、財務決算報告及財務審計報告、利潤分配方案、重新委任德勤為2024年度國際核數師等。此外，還通過了關於未彌補虧損、股東分紅回報規劃、董事會一般授權、發行債務融資工具等議案。監票工作由香港中央證券登記有限公司負責，並有股東代表、律師及監事參與。董事會成員包括執行董事Xuefeng YU博士、Shou Bai CHAO博士、王靖女士，非執行董事李志成先生，以及獨立非執行董事桂水發先生、劉建忠先生及張耀樑先生。
At the 2023 Annual Shareholders' Meeting of Cansinobio held on June 27, 2024, all proposals were officially passed. During the meeting, Mr. Li Zhicheng was elected as a non-executive director of the third board of directors. The shareholders attending the meeting held approximately 34.29% of the issued shares, with the proportion of H-shares and A-shares attending the meeting being 29.12% and 40.28%, respectively. Key resolutions passed at the meeting include board of directors report, supervisory board report, annual report and summary, financial accounting report and financial audit report, profit distribution plan, reappointment of Deloitte as the international auditor for 2024, and other proposals concerning the unrepaired losses, shareholder dividend return plan, general authorization of the board of directors, issuance of debt financing instruments, etc...Show More
At the 2023 Annual Shareholders' Meeting of Cansinobio held on June 27, 2024, all proposals were officially passed. During the meeting, Mr. Li Zhicheng was elected as a non-executive director of the third board of directors. The shareholders attending the meeting held approximately 34.29% of the issued shares, with the proportion of H-shares and A-shares attending the meeting being 29.12% and 40.28%, respectively. Key resolutions passed at the meeting include board of directors report, supervisory board report, annual report and summary, financial accounting report and financial audit report, profit distribution plan, reappointment of Deloitte as the international auditor for 2024, and other proposals concerning the unrepaired losses, shareholder dividend return plan, general authorization of the board of directors, issuance of debt financing instruments, etc. In addition, supervisory work was handled by Hong Kong Central Securities Registry Co., Ltd., with shareholder representatives, lawyers and supervisors participating. Members of the board of directors include executive directors Dr. Xuefeng YU, Dr. Shou Bai CHAO, Ms. Jing WANG, non-executive director Mr. Li Zhicheng, and independent non-executive directors Mr. Shuifa GUI, Mr. Jianzhong LIU and Mr. Yaoliang ZHANG.

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated